Mode
Text Size
Log in / Sign up

rotavirus vaccine

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of rotavirus vaccine

5 trials tracked of rotavirus vaccine: 3 in phase 3 or 4 and 1 with published results. The most-cited published study has 42 citations.

5Trials tracked
3Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 1 Phase 3 2 Phase 2 1 Phase 1 1
  1. Phase 3 Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 4, and 11 to 12 Months (V419-008) Completed · 42 cited
  2. Phase 4 Zinc and/or Probiotic Supplementation of Rotavirus and Oral Polio Virus Vaccines Completed
  3. Phase 3 Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers Completed
  4. Phase 2 A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Infants and Toddlers Completed
  5. Phase 1 Rotavirus Vaccine Produced by Butantan Institute Completed

Showing the 5 most-cited and recently-updated of 5 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.